163 related articles for article (PubMed ID: 8682590)
1. Overexpression of the met/HGF receptor in renal cell carcinomas.
Natali PG; Prat M; Nicotra MR; Bigotti A; Olivero M; Comoglio PM; Di Renzo MF
Int J Cancer; 1996 Jun; 69(3):212-7. PubMed ID: 8682590
[TBL] [Abstract][Full Text] [Related]
2. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
Yang XM; Park M
Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
[TBL] [Abstract][Full Text] [Related]
3. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
4. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
Chen Q; DeFrances MC; Zarnegar R
Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
[TBL] [Abstract][Full Text] [Related]
5. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.
Woolf AS; Kolatsi-Joannou M; Hardman P; Andermarcher E; Moorby C; Fine LG; Jat PS; Noble MD; Gherardi E
J Cell Biol; 1995 Jan; 128(1-2):171-84. PubMed ID: 7822413
[TBL] [Abstract][Full Text] [Related]
6. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
[TBL] [Abstract][Full Text] [Related]
7. C-met proto-oncogene expression in benign and malignant human renal tissues.
Pisters LL; el-Naggar AK; Luo W; Malpica A; Lin SH
J Urol; 1997 Sep; 158(3 Pt 1):724-8. PubMed ID: 9258068
[TBL] [Abstract][Full Text] [Related]
8. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
Zhu H; Naujokas MA; Park M
Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
10. Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells.
Cantley LG; Barros EJ; Gandhi M; Rauchman M; Nigam SK
Am J Physiol; 1994 Aug; 267(2 Pt 2):F271-80. PubMed ID: 8067388
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma.
Konda R; Sato H; Hatafuku F; Nozawa T; Ioritani N; Fujioka T
J Urol; 2004 Jun; 171(6 Pt 1):2166-70. PubMed ID: 15126778
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.
Li Q; Weng J; Mohan RR; Bennett GL; Schwall R; Wang ZF; Tabor K; Kim J; Hargrave S; Cuevas KH; Wilson SE
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):727-39. PubMed ID: 8603858
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis.
Kolatsi-Joannou M; Moore R; Winyard PJ; Woolf AS
Pediatr Res; 1997 May; 41(5):657-65. PubMed ID: 9128288
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.
Yamauchi M; Kataoka H; Itoh H; Seguchi T; Hasui Y; Osada Y
J Urol; 2004 Feb; 171(2 Pt 1):890-6. PubMed ID: 14713848
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
Shi BB; Zhang XH; Wang HJ; Li HZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
[TBL] [Abstract][Full Text] [Related]
19. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.
Olivero M; Rizzo M; Madeddu R; Casadio C; Pennacchietti S; Nicotra MR; Prat M; Maggi G; Arena N; Natali PG; Comoglio PM; Di Renzo MF
Br J Cancer; 1996 Dec; 74(12):1862-8. PubMed ID: 8980383
[TBL] [Abstract][Full Text] [Related]
20. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
Scotlandi K; Baldini N; Oliviero M; Di Renzo MF; Martano M; Serra M; Manara MC; Comoglio PM; Ferracini R
Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
